Management Team
Scientific Team
Board of Directors
Investors

Ampersand Ventures

Founded in 1988, Ampersand is a leading private equity investment firm with offices in Wellesley, MA and San Diego, CA. Ampersand currently manages $550 million in committed capital with investments targeted in the life sciences, information technology, and specialty materials and chemicals sectors. For more information visit: http://www.ampersandventures.com/

New England Partners

Founded in 1992, New England Partners is a Boston based venture capital firm specializing in making equity investments in technology, healthcare, and consumer product companies. During the past twenty years, the professionals at NEP collectively have managed over $700 million in sixteen equity funds and have led investments in over 245 portfolio companies. For more information visit: http://www.nepartners.com/

Novartis Option Fund

The Novartis Option Fund is a $200 million fund that is part of the Novartis Corporate Venture Funds. Established in 1996, the Novartis Venture Funds currently manage over $550 million in committed capital and is invested in more than 50 private companies. The objective of the Novartis Option Fund is to seed innovative companies through initial and follow-on investment. The Novartis Venture Funds team of nine investment professionals located in Basel, Switzerland and Cambridge, Massachusetts, brings together extensive expertise in the biotech and pharmaceutical industry and venture capital. For more information, visit http://www.venturefund.novartis.com

Pappas Ventures

Pappas Ventures is a Research Triangle Park, North Carolina-based venture capital firm that invests nationally in the life science industry. Founded in 1994, Pappas has $250 million under management. The firm's primary investment focus is on product oriented biotechnology and pharmaceutical companies with a secondary focus on medical technologies. For more information visit: http://www.pappasventures.com/